Asarum heterotropoides: A Comprehensive Reference
1. Identity, Taxonomy, and Nomenclature
Asarum heterotropoides Fr. Schmidt is a perennial herbaceous plant belonging to the family Aristolochiaceae. Its primary medicinal form is the variety mandshuricum, rendered in full as Asarum heterotropoides Fr. Schmidt var. mandshuricum (Maxim.) Kitag., though it also appears in older literature under the synonyms Asiasarum heterotropoides (F. Schmidt) F. Maekawa var. mandshuricum (Maximowicz) F. Maekawa and Asarum sieboldii Miquel var. mandshuricum Maximowicz. Asarum from China belongs to the endemic form Asarum heterotropoides f. mandshuricum (Maximowicz) Kitagawa, also designated Asiasarum heterotropoides (F. Schmidt) F. Maekawa var. mandshuricum (Maximowicz) F. Maekawa.
Among the medicinal plants of the genus Asarum, three major species — A. heterotropoides Fr. Schmidt var. mandshuricum (Maxim.) Kitag., A. sieboldii Miq. f. sieboldii, and A. sieboldii Miq. f. seoulense (Nakai) C. Y. Cheng et C. S. Yang — are designated as the official sources of Asari Radix et Rhizoma (ARR) in the Chinese Pharmacopoeia, with A. heterotropoides var. mandshuricum being the mainstream species in the market (over 74% in a survey before 1995).
The crude drug ARR, also commonly known as Xixin (Chinese) and Saishin (Japanese), is the dried roots and rhizomes of these three species. In Korean traditional medicine, the same material is known as seshin. The roots of A. heterotropoides F. Maekawa var. mandshuricum F. Maekawa are used as a medicinal plant in Korea, China, and Japan and known as seshin, xixin, and saishin, respectively.
The genus Asarum originates from Asia, but its members are naturally distributed throughout the temperate zones of the Northern Hemisphere. More specifically, wild Asarum is mainly found in the humid and fertile understory of the Changbai Mountains or in mid-mountainous areas.
1.1 Common Names and Pharmacopoeial Designations
- Chinese (TCM): Xixin (细辛, literally "thin/fine pungent")
- Japanese (Kampo): Saishin
- Korean: Seshin
- Pharmacopoeial drug name: Asari Radix et Rhizoma (ARR)
1.2 Medicinal Part and Common Forms
AH (the plant abbreviated in research) is a perennial plant that is widely used as a traditional herbal medicine in Asian countries. Clinically, it is prescribed together with other traditional Chinese medicines (TCM) to treat several conditions, but not alone due to its toxicity. The crude herb medicine is prepared from its dry root and rhizome as a powder or decoction after boiling for more than 30 minutes.
Common forms include: water decoctions (the most traditional preparation); powders for internal use; powders for external application; and essential oils isolated from the dried rhizome by steam distillation. Internally, the herb is used at 2–6 g by decoction, or 1–3 g when powdered. Externally, an appropriate amount is used in powder form for blowing into the nose, stuffing in the ears, compressing on the navel, or decocted for gargling.
2. Traditional and Historical Use
2.1 Earliest Recorded History
Plants of the genus Asarum have a long medicinal history in China of more than 2,000 years and have been widely used for treatment of cold, headache, rheumatism, and related conditions. ARR was first recorded in the Chinese medical classic Shennong Bencao Jing (Divine Farmer's Materia Medica) and listed as a "top grade" herb, which was indicated as non-toxic at that time.
Due to the fact that the root tastes spicy, it received its name Xi Xin, which has the effect of dispelling wind, dispersing cold, promoting diuresis, and opening the orifices. According to the ancient Chinese medical book Shennong Bencao Jing in the Qin and Han Dynasty, Xi Xin has been used as a top-grade herbal medication with more than 2,000 years of history.
However, in the later classical text Compendium of Materia Medica (Bencao Gangmu) by Li Shizhen, it was stated that "the dosage of ARR should not exceed one coin (approximately 3.75 grams)," which emphasized considerable ARR toxicity and significantly constrained its clinical application.
2.2 Traditions Employing the Herb
The crude drug ARR is widely used as an herbal medicine based on the theory of traditional Chinese medicine (TCM) treatment in China, Japan, Korea, Europe, North America, and other countries or regions, with a very long history.
In traditional Chinese and Korean medicine, Asarum is a herb with pungent and warm properties, believed to specifically target the heart, lungs, and kidneys by exerting its effects through their corresponding body meridians or channels. Its herbal effects include dispelling wind, dispersing cold, relieving pain, warming the lungs, and reducing phlegm.
Since ancient times, Asarum spp. have been widely used as herbal medicine to treat aphthous stomatitis, toothache, and gingivitis in traditional medical practices in China, Korea, and Japan.
2.3 Traditional Indications and Preparations
ARR is traditionally credited with dispelling wind and cold, relieving pain, opening orifices, and warming the lungs to resolve fluid retention. Clinically, it is commonly used to treat the common cold due to cold wind, headache, toothache, nasal congestion with a runny nose, sinusitis, rhinitis, rheumatic pain, and cough with phlegm.
Its synergistic blend with ephedra and aconite can yield a potent effect on inducing sweating and alleviating surface discomfort. In clinical practice, Asari radix et rhizoma is rarely used alone. Instead, it is typically combined with other medicines in herbal formulas to address various conditions.
Classical prescriptions incorporating Xixin include Chuanxiong Chatiao San, which has been clinically used to alleviate migraines, and Chuanxiongxixintang, used to treat neuropathic headaches. The combination of Chuanxiong (CX) and Asarum exerts a synergistic analgesic effect, with classical prescriptions such as Chuanxiong Chatiao San clinically used to alleviate migraines, and Chuanxiongxixintang, used to treat neuropathic headaches.
Ginger and Asarum application by acupoint sticking therapy have been suggested to improve the clinical symptoms of bronchial asthma.
3. Phytochemistry: Key Constituents and Active Compounds
At present, more than 277 compounds have been isolated or identified from genus Asarum. Among them, volatile oil and lignans are the major active constituents and important chemotaxonomic markers.
3.1 Volatile Oil (Essential Oil) Constituents
Plants of the genus Asarum are rich in essential oils (EOs), which are the components possessing biologically or pharmacologically active ingredients. More than 155 compounds have been identified from the EO of genus Asarum, whose main characteristic components are phenylpropanoids (elemicin, safrole, asarone, methyleugenol, myristicin, eugenol, etc.), terpenoid derivatives, and aromatic compounds.
The Asarum essential oil (AEO) is primarily composed of safrole, methyl eugenol, and 3,5-dimethoxytoluene. Studies on the composition of Asarum oil have shown that methyl eugenol, sesamin, safrole, N-isobutyl-(2E,4Z,8Z,10E)-dodecatetraenamide, pentadecane eucarvone, 3,5-dimethoxytoluene, myristicin, and elemicin are present in higher percentages.
Seven key antibacterial principles have been isolated from A. heterotropoides root via bioassay-guided fractionation. The seven antibacterial principles were safrole (1), methyleugenol (2), 1,8-cineole (3), α-asarone (4), δ-3-carene (5), (−)-asarinin (6), and pellitorine (7).
3.2 Lignans
Lignans and their derivatives are important chemical components in genus Asarum, represented by furan lignans. More than 33 lignans have been isolated and identified from genus Asarum. Representative compounds include asarinin and its isomer sesamin, which are found in commonly used medicinal species such as A. heterotropoides.
The health-promoting properties are due to the composition of their metabolomes, in particular the EOs, monoterpenes, lignans, alkaloids, alcohols, asarinin, and amides. Asarinin from Asarum species has strong bioactivity such as anticancer, antihypertensive, and antiangiogenic activities.
A 2017 phytochemical investigation identified numerous novel lignan structures. Nine new compounds were isolated from the ethanol extract of A. heterotropoides var. mandshuricum, including six new lignans — neoasarinin A–C (1–3), neoasarininoside A and B (4 and 5), and asarinin B (7) — one new monoterpene asarincin A (8), two new amides asaramid II and III (10 and 11), and one new natural monoterpene asaricin B (9), along with 37 known compounds.
3.3 Other Compound Classes
The ethanolic extracts consist of lignans, monoterpenes, phenanthrene derivatives, isobutyl amides, and phenylpropanoids. Phytochemical studies on this herb showed that the components of Asarum include volatile oil, flavonoids, aristolochic acids, and furofuran-type lignans.
3.4 Aristolochic Acid Analogues
However, Asarum spp. source plants contain nitrophenanthrene organic acids called aristolochic acids (AAs) that were verified to be toxic. AAs exhibit nephrotoxicity, liver toxicity, carcinogenesis, and mutagenesis and are classified as grade I carcinogens. Further studies indicate that AAs have multiple types of molecular structure, with aristolochic acid I (AAI) being the most toxic.
The results of quantitative analysis showed that the contents of AA I, AA II, and AA IIIa were below the detection limit, while AA IVa and AL I presented relatively high contents of Asarum heterotropoides F. Schmidt (Xixin), within the range of 66.50–121.03 μg/g and 19.73–43.75 μg/g, respectively.
4. Mechanisms of Action
4.1 Anti-Inflammatory Mechanisms
Among the characteristic constituents, COX-2 is a key target, which interacts with five characteristic constituents: asarinin, sesamin, safrole, methyleugenol, and sarisan. Of these, asarinin and sesamin also interacted with iNOS and MAPK14, and safrole and sarisan also interacted with additional targets.
Since asarinin and sesamin interacted with three targets — COX-2, iNOS, and MAPK14 — it is implied that they are the main active constituents for the anti-inflammatory activity of Asari Radix et Rhizoma.
It is speculated that the lignans containing tetrahydrofuran may be the major components of the non-volatile fraction to exert anti-inflammatory activity. The volatile oil of ARR was also considered the main effective component contributing to analgesia and anti-inflammation.
4.2 Analgesic and Local Anesthetic Mechanisms
The anesthetic properties of methyleugenol have been demonstrated by a loss of the righting reflex and decreased sensitivity to tail pinching in rats and mice, and a loss of the corneal reflex in rabbits. Wang et al. suggested that the antinociceptive and anesthetic effects of methyleugenol result from the inhibitory action of methyleugenol on peripheral Na+ channels, making methyleugenol a potential candidate as an effective local anesthetic.
4.3 Cardiovascular Mechanisms
Asarum can improve the metabolic function of the body. It has extensive pharmacological effects such as receptor agonism, which can strengthen the heart, dilate blood vessels, relax smooth muscle, and enhance lipid metabolism.
The mechanism of action of sesamin occurs through the inhibition of TNF-α-induced NF-κB translocation, intercellular adhesion molecule-1 expression, and monocyte adhesion. Sesamin also triggers eNOS activity and NO production via activation of TRPV1-calcium signaling, including the phosphorylation of PKA, CaMKII, CaMKKβ, Akt, and AMPK.
4.4 Antioxidant Mechanisms
Sesamin and asarinin play significant roles in the antioxidant activities. Asarum can improve the activity of nitric oxide synthase (iNOS), reduce the content of malondialdehyde (MDA), scavenge free radicals, increase the content of NO, and reduce the damage of oxygen free radicals to cell lipids. It can also increase the activity of SOD, enhance the body's ability to scavenge free radicals, and reduce the damage of free radicals to the body.
4.5 Antidepressant Mechanisms
A study investigated the effects of essential oil from Asarum heterotropoides (EOAH) on depression-like behaviors and brain expressions of CRF, 5-HT, and TH in mice challenged with stress. Male ICR mice received fragrance inhalation of EOAH (0.25, 0.5, 1.0, and 2.0 g) for 3 hours in a special cage before the forced swimming test (FST) and tail suspension test (TST). The duration of immobility was measured for the determination of depression-like behavior. EOAH at higher doses (1.0 and 2.0 g) reduced immobility time in the FST and TST. These results are animal-based and have not been replicated in human clinical trials.
5. Scientific Evidence by Area of Use
5.1 Analgesia and Anti-Nociception
Historically, A. heterotropoides has long been used as an analgesic and antitussive agent for the treatment of influenza, headache, rheumatic pain, and asthma.
Essential oil (EO) and ethanolic extract (EE) showed a dose-dependent reduction in the degree of swelling and an increase in the inhibition rate on acetic acid writhing in mice. Asarum EO proved to be more effective than EE in the pharmacodynamic study. The evidence for analgesic effects in humans is indirect: classical TCM formulas such as Chuanxiong Chatiao San have been used clinically, but the human clinical trial evidence specific to A. heterotropoides as an isolated agent remains limited and primarily based on preclinical (in vivo animal) data.
5.2 Anti-Inflammatory Activity
Xixin has anti-inflammatory, anticancer, antibacterial, and analgesic effects, and is commonly used in TCM to treat colds, headaches, toothaches, rhinorrhoea, wheezing, inflammation, and others.
The anti-inflammatory phytochemical investigation published in the journal Molecules (2017) conducted in vitro assays on isolated compounds. Anti-inflammatory compounds were investigated from the ethanol extract of the roots and rhizomes of Asarum heterotropoides var. mandshuricum, a TCM called Xixin used for pain and inflammation. Nine new compounds were isolated, including six new lignans, one new monoterpene, and two new amides. This study was in vitro and did not extend to human trials.
Asarum essential oil (AEO) exhibits good anti-inflammatory activity and considerable toxicity. The original oil and all three molecular distillation fractions exhibited anti-inflammatory effects. This evidence is entirely preclinical (cell and animal models). No robust randomized controlled trials in humans on A. heterotropoides as a defined anti-inflammatory agent have been identified in the available literature.
5.3 Antitussive and Respiratory Effects
Extracts of Asarum heterotropoides have significant antitussive activity in the guinea pig model for chronic cough induced by (2-chlorobenzylidene)malononitrile exposure, which might be related to anti-inflammatory and antioxidant activity.
Ginger and Asarum application by acupoint sticking therapy have been suggested to improve the clinical symptoms of bronchial asthma. This evidence is preclinical or based on traditional combinatorial therapy reports and does not constitute controlled clinical trial evidence for the isolated herb.
5.4 Antimicrobial Activity
In the screening of plants for antibacterial activity, a methanol extract of Asarum heterotropoides (Aristolochiaceae) was shown to have growth inhibitory activity against Bacteroides fragilis ATCC 25285 and Clostridium perfringens ATCC 13124.
As judged by MIC values, δ-3-carene showed the most potent growth inhibitory activity against four Gram-positive bacteria (MIC 0.18–0.70 mg/mL) and two Gram-negative bacteria (0.18–0.70 mg/mL) except for S. enterica serovar Typhimurium (2.94 mg/mL).
Zhang showed that L-asarinin, L-sesamin, and kakuol had antibacterial activities against Escherichia coli, Staphylococcus aureus, pneumonia, Pseudomonas aeruginosa, and Candida albicans. All antimicrobial evidence is in vitro. No human clinical trials have been identified.
5.5 Anti-HPV Activity
Deng et al. screened the anti-HPV effective fraction from Asarum heterotropoides and found that the water extracts were effective against Human papillomavirus, with a minimum effective concentration of 0.4 g/mL. This is an in vitro finding. No clinical studies in humans are documented in the available literature.
5.6 Antidepressant Effects
A preclinical animal study (Kim et al.) examined inhalation of EOAH. The study investigated the effects of EOAH on depression-like behaviors and brain expressions of CRF, 5-HT, and TH in mice challenged with stress, using fragrance inhalation of EOAH (0.25, 0.5, 1.0, and 2.0 g) for 3 hours. EOAH at higher doses (1.0 and 2.0 g) reduced immobility time in the FST and TST. This is animal-only evidence; no human trials have been reported.
5.7 Cardiovascular Effects
Asarum serves a pivotal role in safeguarding the cardiovascular system, enhancing the circulation of blood, and supporting the maintenance of normal metabolic activity within the body. Methyleugenol was found to inhibit the production of NO and decreased the protein expression of iNOS, down-regulated the production of pro-inflammatory cytokines in the ischemic brain as well as in immune-stimulated mixed glial cells, indicating that methyleugenol can be useful for treatment of ischemia/inflammation-related diseases. Cardiovascular evidence is preclinical (cell and animal-based) and mechanistic only.
5.8 Anti-Cancer Activity
Modern pharmacological studies indicated that genus Asarum and its active compounds possess a wide range of pharmacological effects, especially analgesic, anti-inflammatory, neuroprotective, cardiovascular protection, antitussive, immunosuppressive, anti-tumor, and microbicidal activities. Anti-tumor evidence is entirely preclinical (in vitro and animal models) and should be characterized as exploratory at this stage.
5.9 Overall Strength of Evidence
Based on the available reviews, therapeutic potential of genus Asarum has been demonstrated with pharmacological effects on inflammation, CNS, respiratory regulation, cardiovascular diseases, cancer, and microbial infection. The available literature shows that the major activities can be attributed to the active lignans and essential oils. However, the overwhelming majority of this evidence comes from in vitro cell studies and in vivo animal experiments. Robust, randomized, double-blind, placebo-controlled human clinical trials specifically on Asarum heterotropoides as an isolated agent are lacking in the published literature.
6. Body Systems and Health Areas of Association
Modern pharmacological studies indicated that genus Asarum and its active compounds possess a wide range of pharmacological effects, especially analgesic, anti-inflammatory, neuroprotective, cardiovascular protection, antitussive, immunosuppressive, anti-tumor, and microbicidal activities. The therapeutic potential has been demonstrated with pharmacological effects on inflammation, CNS, respiratory regulation, cardiovascular diseases, cancer, and microbial infection.
- Central Nervous System: Analgesic, local anesthetic, antidepressant (preclinical), neuroprotective
- Cardiovascular System: Vasodilation, cardiac strengthening, anti-ischemic (preclinical)
- Respiratory System: Antitussive, anti-asthmatic, mucolytic (traditional and preclinical)
- Immune System: Anti-inflammatory (COX-2, iNOS, MAPK14 modulation), immunosuppressive
- Oral and Dental: Local anesthetic for toothache, anti-stomatitis
- Gastrointestinal: Growth inhibition of harmful intestinal bacteria (in vitro)
- Antioxidant: SOD, GSH-Px activation and MDA reduction (animal studies)
7. Dosage Forms and Reported Dosages
Dosages documented in traditional pharmacopeial and clinical literature are as follows:
- Internal decoction: 2–6 g; or as powder, 1–3 g.
- External use: An appropriate amount in powdered form for blowing into the nose, stuffing in ears, compressing on the navel, or decocted for gargling.
- Historical maximum dose: Li Shizhen's Compendium of Materia Medica specified that the dosage of ARR should not exceed one coin (approximately 3.75 grams).
In preclinical chronic toxicity research, oral doses to mice equivalent to 0.5, 1.6, and 5.0 g/kg of AH decoction (approximately 10–100 times clinical human doses) were employed in a parallel-design toxicity study. A parallel design was employed to examine the potential chronic toxicity of AH decoction at doses equivalent to 0.5, 1.6, and 5.0 g/kg AH (approximately 10–100 times the clinical doses for humans) and its major AA components at doses equivalent to that in 5.0 g/kg AH to mice after consecutive daily oral administration for 12 and 24 weeks.
In the 2024 rat safety study: The single-dose toxicity study showed no changes in body weight, clinical pathology, or macroscopic findings, with the approximate lethal dose (ALD) exceeding 5,000 mg/kg. The 13-week repeated-dose toxicity study demonstrated no treatment-related changes in body weight, general symptoms, hematology, clinical chemistry, or urinalysis. The no observed adverse effect level (NOAEL) for both male and female rats was estimated to be 2,000 mg/kg.
8. Safety Considerations
8.1 Aristolochic Acid Nephrotoxicity
While A. heterotropoides f. mandshuricum is widely used to treat influenza, COVID-19, allergic rhinitis, headache, toothache, rheumatoid arthritis, and peptic ulcer, its clinical use is controversial due to the concern of aristolochic acid nephropathy (AAN) caused by its component aristolochic acid analogs (AAs).
Aristolochic acid is absorbed and conjugates to albumin in the bloodstream, then influxes into proximal tubular epithelial cells via organic anion transporters (OAT) 1 and 3. Once inside the cells, AA rapidly reacts with DNA to produce AA-adducts, which can lead to cytotoxicity and induce cancer.
In recent years, AA I was statistically associated with the incidence of hepatocellular carcinoma. Although the content of AA I in Asarum (Xixin) is required to be less than 0.001% according to the Chinese Pharmacopoeia 2020, the contents of AA analogues in herbs and their commercial products are still not fully characterized.
8.2 Differentiated Risk of AA Analogues in This Species
Plants of Aristolochiaceae have been gradually prohibited in clinical use due to the nephrotoxicity and carcinogenicity of AA, with the exception of Asarum (Xixin), which has been used for centuries as an analgesic and antitussive. Asarum (Xixin) contains relatively low levels of AA I and AA II in roots and rhizomes; therefore, it is considered a safer drug and is widely used in traditional Chinese medicines.
AA I and AL I exhibited relatively high cytotoxicity at 48 hours in CCK8 assays, while AA II, AA IIIa, and AA IVa showed weak cytotoxicity even at 800–1,000 μM. AA I induced significant pathological alterations and direct DNA damage at 40 mg/kg and 20 mg/kg, respectively. No distinct nephrotoxicity or hepatotoxicity was observed in mice treated with AA II, AA IIIa, AA IVa, or AL I at 40 mg/kg in this study.
Consumption of Asarum heterotropoides F. Schmidt (Xixin) with controlled doses and periods is relatively safe as the contents of AA analogues in Xixin and its formulations were far below those causing acute toxicity in this study. However, the long-term toxicity of Xixin still needs further study.
8.3 Hepatotoxicity
Previous studies have detected a number of potentially toxic components in asarum, including safrole, methyl eugenol, aristolochic acids, asarone, 3,5-dimethoxytoluene, and benzene derivatives. These components are associated with toxicity in multiple organs, including the central nervous system, kidneys, and liver.
Transcriptomics and metabolomics analyses in rats following intragastric administration of asarum powder were performed to examine hepatotoxicity mechanisms. Specifically, mRNA and metabolites were obtained from rat liver samples following intragastric administration of asarum powder. RNA sequencing analysis identified a total of 434 differentially expressed genes (DEGs) in liver tissue samples, 214 of which were upregulated and 220 were downregulated.
8.4 Neurotoxicity
Asarum essential oil (AEO) exhibits good anti-inflammatory activity and considerable toxicity. The potential mechanism of neurotoxicity is related to oxidative stress and apoptosis. Most of the current methods of reducing the toxicity of Asarum are based on increasing the decoction time and reducing the essential oil content.
8.5 Genotoxicity Findings: Decoction vs. Powder
An important distinction has emerged between the decoction (boiled water extract) form and the raw powder form of the herb. The genotoxicity tests revealed that the AR decoction extract was not genotoxic. In contrast, Asiasari Radix et Rhizoma (AR) powder induced genotoxicity in Ames and chromosomal aberration (CA) tests. In the comet assay, positive results in the stomach were shown at 500 and 2,000 mg/mL. AR powder induced hyperplasia of the stomach and hepatocellular adenoma in the liver.
These findings underscore the pharmacopoeial distinction between boiled decoctions — in which heat-labile and volatile toxic components (including volatile oil fractions) are substantially reduced — and raw powder preparations.
8.6 Decoction's Reduction of Toxic Volatile Compounds
Among the components of Asarum, volatile oils are not only the major bioactive compounds but also the toxic compounds. They have attracted wide attention from researchers because of their high content and strong activities. Traditional preparation by boiling substantially reduces concentrations of safrole and methyleugenol compared to raw powders, which explains the differential toxicity profiles observed in preclinical studies.
8.7 Safrole and Methyleugenol: Regulatory Concern
Methyleugenol and safrole, along with aristolochic acid analogues, may be the main toxic ingredients when taking an overdose. Safrole and methyleugenol are well-recognized hepatocarcinogenic and genotoxic agents in regulatory science; their presence in Asarum volatile oil has attracted regulatory scrutiny in Europe and elsewhere, where the herb's use is significantly restricted.
8.8 Long-Term Renal Safety
A 2023 study specifically evaluating chronic oral administration of AH decoction reported reassuring findings at pharmacologically relevant doses. Clinically, AH is prescribed together with other traditional Chinese medicines to treat influenza, novel coronavirus-induced pneumonia, allergic rhinitis, headache, toothache, rheumatoid arthritis, and peptic ulcer, but not alone due to its toxicity. The chronic toxicity investigation showed that at clinically equivalent doses, AH decoction and its isolated AA analog components did not produce overt renal toxicity in the murine model, though long-term safety data in humans remain incomplete.
8.9 Summary of Key Safety Points
- Raw powder vs. decoction: Raw powder has demonstrated genotoxicity in preclinical assays; decoction extract has not shown this profile in the same testing battery, consistent with the traditional practice of boiling the herb.
- Aristolochic acid I limits: The Chinese Pharmacopoeia 2020 sets an upper limit for AA I content at less than 0.001% in the crude drug.
- Volatile oil toxicity: Safrole and methyleugenol are major volatile oil components associated with hepatocarcinogenic and genotoxic potential; their concentrations are substantially reduced by prolonged decoction.
- Multi-organ toxicity concern: Potentially toxic effects on the CNS, kidneys, and liver have been documented in preclinical models at supratherapeutic doses.
- Combinatorial use: Traditional use is predominantly in multi-herb formulas, and clinical use of isolated A. heterotropoides as a single agent is specifically cautioned against in classical texts and modern pharmacopoeial guidelines.
- NOAEL (decoction, rat): The no observed adverse effect level (NOAEL) for both male and female rats was estimated to be 2,000 mg/kg in the 13-week repeated-dose study using the decoction extract.
References
Go back